Buchan Consulting

Buchan is a premier Australian strategic communications and investor relations consultancy with a specialized focus on the life sciences and healthcare industries. The company provides a comprehensive suite of services, including financial PR, corporate communications, and crisis management, tailored for biotechnology and medical technology firms. In 2016, Buchan was acquired by Ogilvy PR, a member of the WPP network, to integrate its specialized investor relations capabilities into Ogilvy's broader communications platform. The firm is well-regarded for its role in supporting ASX-listed life science companies through clinical milestones, regulatory approvals, and capital market transactions. Its team is known for navigating the complex regulatory and clinical communication requirements unique to the healthcare industry, making it a dominant player in the Australian biotech ecosystem.